Jump to content

Tazolol

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Htmlzycq (talk | contribs) at 04:03, 4 March 2023 (removed Category:Amines; added Category:Secondary amines using HotCat). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Tazolol
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC9H16N2O2S
Molar mass216.30 g·mol−1
3D model (JSmol)
  • CC(C)NCC(COC1=NC=CS1)O

Tazolol is a beta blocker with some utility in the treatment of heart disease.[1]

See also

[edit]

References

[edit]
  1. ^ Strosberg AM (August 1976). "The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant". Archives Internationales de Pharmacodynamie et de Therapie. 222 (2): 200–15. PMID 010864.
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Tazolol&oldid=1142746970"